Clinical trials: Coronary Artery Disease Left Main
Percutaneous Coronary Intervention, Coronary Artery Disease
Clinical Evaluation of A New High-speed and High-resolution Intravascular Ultrasound System
Insight Lifetech Intravascular Ultrasound Diagnostic System (referred to as Insight Lifetech IVUS system below),is a new high-speed and high-resolution device for clearly defining vessel architecture and plaque morphology…
- Conditions
- Percutaneous Coronary Intervention, Coronary Artery Disease, Chronic Total Occlusion of Coronary Artery, Left Main Coronary Artery Disease
- Trial name
- NEW-IVUS (NCT04739657)
- Testing
- Insight Lifetech IVUS System, Boston Scientific IVUS System
- Where
- 5 sites in China
- Volunteers
- 130 people
- Sponsor
- Insight Lifetech Co., Ltd.
Coronary Heart Disease
The Study of Active Transfer of Plaque Technique for Non-Left Main Coronary Bifurcation Lesions
A Prospective Multi-center Randomized Trial Assessing the Efficacy and Safety of Active Transfer of Plaque vs. Provisional T Stenting for the Treatment of Non-Left-Main Coronary Bifurcation Lesions.
- Trial name
- NCT02768116
- Testing
- Sirolimus Drug-eluting Stent via Active Transfer of Plaque, Sirolimus Drug-eluting Stent implantation via Provisional T Stenting
- Volunteers
- 316 people
- Sponsor
- Beijing Anzhen Hospital
Coronary Artery Disease
Observational Study for Left Main Disease Treatment
The purpose of this study is to observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for…
- Trial name
- IRIS-MAIN (NCT01341327)
- Where
- 42 sites in China, Malaysia and 3 more
- Volunteers
- 10,000 people
- Sponsor
- Seung-Jung Park
Unprotected Left Main Coronary Artery Disease
Comparison of HYBRID Versus Two-Stent Strategies in Unprotected True Left MAIN Bifurcation
The number of deaths from heart disease is rising globally, particularly in developing countries. This condition involves the narrowing of arteries that supply blood to the heart.
- Trial name
- HYBRID MAIN (NCT07159737)
- Testing
- Two-stent strategy, Hybrid Strategy
- Volunteers
- 800 people
- Sponsor
- Hospital Sultanah Bahiyah
Left Main Coronary Artery Disease, Stenosis
Stress Echocardiography Versus Coronary Angiography for Left Main Stenosis Detection
Left main stenosis use to be treated by bypass but with the improvement of angioplasty techniques, an increasing number of patients are submit to left main coronary angioplasty.
- Trial name
- ESTRIE-TC (NCT01620320)
- Testing
- Stress echocardiography
- Where
- Canada
- Sponsor
- Université de Sherbrooke
Coronary Artery Disease, Coronary Artery Disease (Left Main)
µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
Murray-law based single-view quantitative flow ratio (µQFR) has been recommended for guiding percutaneous coronary intervention (PCI) in selective patients.
- Conditions
- Coronary Artery Disease, Coronary Artery Disease (Left Main), Obstructive Coronary Artery Disease, Stent Implantation
- Trial name
- NCT07116083
- Where
- China
- Volunteers
- 290 people
- Sponsor
- Shanghai Zhongshan Hospital
Coronary Arteriosclerosis
Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent
The purpose of this study is to determine whether percutaneous coronary angioplasty with Taxus drug eluting stent is safe and effective in the treatment of unprotected left main coronary artery disease associated to other…
- Trial name
- NCT00300157
- Testing
- Percutaneous coronary intervention with Taxus stent
- Where
- 26 sites in France
- Volunteers
- 155 people
- Sponsor
- French Cardiology Society
Chronic Coronary Occlusion, Left Main Coronary Artery Disease
EXCEL Clinical Trial (Universal Registry)
The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized…
- Conditions
- Chronic Coronary Occlusion, Left Main Coronary Artery Disease, Stent Thrombosis, Vascular Disease
- Trial name
- EXCEL (NCT01205789)
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- Abbott Medical Devices
Anterior Wall Acute Myocardial Infarction
Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT)
The primary objective of the study is to collect confirmatory data supporting the safety and effectiveness of SSO2 Therapy in treatment of anterior acute myocardial infarction (AMI) patients who have undergone successful…
- Trial name
- IC-HOT (NCT02603835)
- Testing
- SSO2 Therapy
- Where
- 15 sites in United States
- Volunteers
- 100 people
- Sponsor
- TherOx
Coronary Artery Disease Left Main
Antegrade and Retrograde Versurs Antegrade Cardioplegia in Complex Coronary Artery Bypass Surgeries
During coronary artery bypass surgery, myocardial protection, especially of the right ventricle, may be inadequate in the presence of severe coronary lesions that obstruct the antegrade delivery of cold cardioplegia
- Trial name
- NCT04439162
- Testing
- retrograde cardioplegia protection
- Volunteers
- 100 people
- Sponsor
- Assiut University
Coronary Artery Disease
Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)
This study is a multicenter, open label, prospective, single arm trial Single arm group; following angiography, eligible patients with unprotected LMCA stenosis >50% by visual estimation, which is equally treatable by the both…
- Trial name
- NCT01348022
- Where
- 21 sites in South Korea
- Volunteers
- 397 people
- Sponsor
- Seung-Jung Park
Chronic Coronary Occlusion, Unprotected Left Main Coronary Artery Disease
EXCEL Clinical Trial
To establish the safety and efficacy of the commercially approved XIENCE Family Stent System (inclusive of XIENCE PRIME, XIENCE V, XIENCE Xpedition and XIENCE PRO [for use outside the United States [OUS] only]) in subjects with…
- Conditions
- Chronic Coronary Occlusion, Unprotected Left Main Coronary Artery Disease, Stent Thrombosis, Vascular Disease
- Trial name
- EXCEL (NCT01205776)
- Testing
- Percutaneous Coronary Intervention, CABG
- Where
- United States
- Volunteers
- 1,905 people
- Sponsor
- Abbott Medical Devices
Myocardial Infarction
Safety and Feasibility of Using a Single Transradial Guiding Catheter for Primary PCI
The Rapid Trial is a randomized-controlled trial proposed to test the hypothesis that using a single guiding catheter for left and right coronary angiography and intervention in patients with ST elevation myocardial infarction…
- Trial name
- RAPID (NCT01759043)
- Testing
- guiding catheter, diagnostic catheter
- Where
- China
- Volunteers
- 360 people
- Sponsor
- Beijing Luhe Hospital
Coronary Stenosis, Stent Stenosis
Culotte Versus DK-CRUSH Technique in Non-left Main Coronary Bifurcation Lesions
Randomised comparison of Culotte technique versus "Double Kissing" - Crush technique (DK-Crush) for the percutaneous treatment of de novo non-left main coronary bifurcation lesions with modern everolimus-eluting stents (DES) …
- Trial name
- BBK-3 (NCT04192760)
- Testing
- Stenting
- Where
- 13 sites in Germany
- Volunteers
- 400 people
- Sponsor
- University Heart Center Freiburg - Bad Krozingen
Coronary Artery Disease
Ten-Year Outcomes of PRE-COMBAT Trial
This study evaluates Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis(PRECOMBAT trial).
- Trial name
- PRECOMBAT (NCT03871127)
- Testing
- Percutaneous coronary intervention, coronary artery bypass graft
- Where
- 9 sites in South Korea
- Volunteers
- 600 people
- Sponsor
- Seung-Jung Park
Coronary Artery Disease
Simple Crossover Versus Side Branch Opening in Patients With Non-Left Main Bifurcation Lesion
Hypothesis: Simple crossover strategy would be non-inferior to SB opening strategy in the risk of target lesion failure (TLF) in patients with angiographically compromised SB (visually SB stenosis ≥50%) after provisional MV…
- Trial name
- CROSS-COBIS (NCT05705362)
- Testing
- Simple Crossover, Side branch opening
- Volunteers
- 1,000 people
- Sponsor
- Keimyung University Dongsan Medical Center
Coronary Artery Disease
Outcomes of Surgically Ineligible Patients With Multivessel CAD
The OPTIMUM registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease ("surgical anatomy" according to ACC/AHA…
- Trial name
- OPTIMUM (NCT02996877)
- Where
- 21 sites in United States
- Volunteers
- 750 people
- Sponsor
- Saint Luke's Health System
Coronary Arteriosclerosis, Left Main Coronary Artery Disease
Registry on Left Main Coronary Artery Bifurcation Percutaneous Intervention
The slowly accruing evidence on the treatment of patients with left main coronary artery (LMCA) disease drove evolution in guidelines, that currently establish equivalent safety and efficacy for percutaneous coronary intervention…
- Trial name
- WE REMAIN EBC (NCT04321473)
- Testing
- PCI on left main
- Volunteers
- 1,500 people, healthy volunteers welcome
- Sponsor
- G. d'Annunzio University
Coronary Artery Disease, Left Main Coronary Artery Disease
IVUS VS CAG Guided PCI for Patients With LMB Lesion
To compare the 3 - year clinical follow - up results of patients with left main bifurcation lesions treated by intravascular ultrasound(IVUS) - guided and coronary angiography(CAG) - guided percutaneous coronary…
- Trial name
- Infinite (NCT04072003)
- Testing
- intravascular ultrasound (IVUS), coronary angiography
- Volunteers
- 616 people
- Sponsor
- Shanghai Zhongshan Hospital
Coronary Artery Disease
Xience Versus Synergy in Left Main PCI
A prospective, randomized, multicenter study in patients with an indication for coronary artery revascularisation who have been accepted for percutaneous coronary intervention (PCI) of the left main coronary artery.
- Trial name
- IDEAL-LM (NCT02303717)
- Testing
- Percutaneous coronary intervention, Dual antiplatelet therapy
- Volunteers
- 818 people
- Sponsor
- NHS National Waiting Times Centre Board